Tags

Type your tag names separated by a space and hit enter

Capabilities of Next-Generation Patch Pump: Improved Precision, Instant Occlusion Detection, and Dual-Hormone Therapy.
J Diabetes Sci Technol. 2019 01; 13(1):49-54.JD

Abstract

Insulin pumps allow patients to attain better blood glucose control with more lifestyle flexibility. Their size and cost, however, limit their usefulness. Current CSII pumps are bulky, intrusive, and expensive. SFC Fluidics is addressing these problems by developing a new type of wearable patch pump based on the patented electro-chemiosmotic (ECO) microfluidic pumping technology. This nonmechanical pumping technology allows accurate and precise delivery of very small amounts of insulin and/or other drugs, including concentrated insulin. The pump engine is small and can be made inexpensively from injection molded parts, allowing its use in a disposable or semidisposable pod format. In addition, a single ECO pump engine can be used to deliver two drugs through independent pathways. Other features of SFC Fluidics' pod include latching safety valves that prevent accidental overdosing of insulin due to pressure changes and an instantaneous occlusion sensor that can immediately detect delivery failure at the first missed dose. These features allow for the development of a series of patch pumps that will offer users the benefit of CSII therapy in a more discreet and reliable patch pump form.

Authors+Show Affiliations

1 SFC Fluidics, Inc, Fayetteville, AR, USA.1 SFC Fluidics, Inc, Fayetteville, AR, USA.1 SFC Fluidics, Inc, Fayetteville, AR, USA.

Pub Type(s)

Journal Article
Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, Non-P.H.S.

Language

eng

PubMed ID

29792066

Citation

Payne, Forrest W., et al. "Capabilities of Next-Generation Patch Pump: Improved Precision, Instant Occlusion Detection, and Dual-Hormone Therapy." Journal of Diabetes Science and Technology, vol. 13, no. 1, 2019, pp. 49-54.
Payne FW, Ledden B, Lamps G. Capabilities of Next-Generation Patch Pump: Improved Precision, Instant Occlusion Detection, and Dual-Hormone Therapy. J Diabetes Sci Technol. 2019;13(1):49-54.
Payne, F. W., Ledden, B., & Lamps, G. (2019). Capabilities of Next-Generation Patch Pump: Improved Precision, Instant Occlusion Detection, and Dual-Hormone Therapy. Journal of Diabetes Science and Technology, 13(1), 49-54. https://doi.org/10.1177/1932296818776028
Payne FW, Ledden B, Lamps G. Capabilities of Next-Generation Patch Pump: Improved Precision, Instant Occlusion Detection, and Dual-Hormone Therapy. J Diabetes Sci Technol. 2019;13(1):49-54. PubMed PMID: 29792066.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Capabilities of Next-Generation Patch Pump: Improved Precision, Instant Occlusion Detection, and Dual-Hormone Therapy. AU - Payne,Forrest W, AU - Ledden,Bradley, AU - Lamps,Greg, Y1 - 2018/05/24/ PY - 2018/5/25/pubmed PY - 2020/4/25/medline PY - 2018/5/25/entrez KW - artificial pancreas KW - automated insulin delivery KW - concentrated insulin KW - dual-hormone therapy KW - insulin patch pump KW - occlusion detection SP - 49 EP - 54 JF - Journal of diabetes science and technology JO - J Diabetes Sci Technol VL - 13 IS - 1 N2 - Insulin pumps allow patients to attain better blood glucose control with more lifestyle flexibility. Their size and cost, however, limit their usefulness. Current CSII pumps are bulky, intrusive, and expensive. SFC Fluidics is addressing these problems by developing a new type of wearable patch pump based on the patented electro-chemiosmotic (ECO) microfluidic pumping technology. This nonmechanical pumping technology allows accurate and precise delivery of very small amounts of insulin and/or other drugs, including concentrated insulin. The pump engine is small and can be made inexpensively from injection molded parts, allowing its use in a disposable or semidisposable pod format. In addition, a single ECO pump engine can be used to deliver two drugs through independent pathways. Other features of SFC Fluidics' pod include latching safety valves that prevent accidental overdosing of insulin due to pressure changes and an instantaneous occlusion sensor that can immediately detect delivery failure at the first missed dose. These features allow for the development of a series of patch pumps that will offer users the benefit of CSII therapy in a more discreet and reliable patch pump form. SN - 1932-2968 UR - https://www.unboundmedicine.com/medline/citation/29792066/Capabilities_of_Next-Generation_Patch_Pump:_Improved_Precision,_Instant_Occlusion_Detection,_and_Dual-Hormone_Therapy DB - PRIME DP - Unbound Medicine ER -